Motus GI (MOTS) Competitors $0.0008 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends MOTS vs. VRAYQ, AHPI, NMRD, BRSH, DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, and HSCSWShould you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry. Motus GI vs. ViewRay Allied Healthcare Products Nemaura Medical Bruush Oral Care Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories Motus GI (NASDAQ:MOTS) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends. Does the MarketBeat Community favor MOTS or VRAYQ? Motus GI received 163 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformMotus GIOutperform Votes16365.73% Underperform Votes8534.27% ViewRayN/AN/A Does the media refer more to MOTS or VRAYQ? In the previous week, Motus GI's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score. Company Overall Sentiment Motus GI Neutral ViewRay Neutral Do insiders and institutionals hold more shares of MOTS or VRAYQ? 20.1% of Motus GI shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 2.5% of ViewRay shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has stronger valuation and earnings, MOTS or VRAYQ? Motus GI has higher earnings, but lower revenue than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMotus GI$320K0.01-$12.87M-$15.640.00ViewRay$102.21M0.00-$107.33MN/AN/A Which has more risk and volatility, MOTS or VRAYQ? Motus GI has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, ViewRay has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Is MOTS or VRAYQ more profitable? ViewRay has a net margin of 0.00% compared to Motus GI's net margin of -3,239.75%. ViewRay's return on equity of 0.00% beat Motus GI's return on equity.Company Net Margins Return on Equity Return on Assets Motus GI-3,239.75% -1,731.08% -115.99% ViewRay N/A N/A N/A SummaryViewRay beats Motus GI on 5 of the 9 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Motus GI News Delivered to You Automatically Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MOTS vs. The Competition Export to ExcelMetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$4.42B$5.06B$8.82BDividend YieldN/A41.17%5.18%4.07%P/E Ratio0.0024.81126.3117.81Price / Sales0.0147.031,178.7474.57Price / CashN/A51.8733.8632.53Price / Book0.004.974.684.68Net Income-$12.87M$13.76M$119.54M$226.08M7 Day PerformanceN/A-1.08%-1.83%-1.04%1 Month PerformanceN/A0.58%-3.60%1.04%1 Year PerformanceN/A50.91%31.91%26.28% Motus GI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MOTSMotus GIN/A$0.00flatN/A-100.0%$5,000.00$320,000.000.0030VRAYQViewRayN/AN/AN/AN/A$20,000.00$102.21M0.00300AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150NMRDNemaura MedicalN/AN/AN/AN/A$10,000.00$80,000.000.0040BRSHBruush Oral CareN/A$0.00flatN/A-99.7%$1,000.00$2.92M0.0011DRTSWAlpha Tau MedicalN/A$0.22+29.8%N/A-15.4%$0.00N/A0.0080News CoverageGap UpANZUWAnzu Special Acquisition Corp IN/A$0.06flatN/AN/A$0.00N/A0.002BBLGWBone BiologicsN/A$28.49flatN/AN/A$0.00N/A0.002BRSHWBruush Oral CareN/A$0.01flatN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/A$0.02flatN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.03flatN/AN/A$0.00$18,600.000.0010 Related Companies and Tools Related Companies VRAYQ Alternatives AHPI Alternatives NMRD Alternatives BRSH Alternatives DRTSW Alternatives ANZUW Alternatives BBLGW Alternatives BRSHW Alternatives GMVDW Alternatives HSCSW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MOTS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Motus GI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.